These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5482837)

  • 1. [17-ketosteroid changes in breast cancer during testosterone propionate treatment].
    Mindlin SS; Smiller RR
    Vopr Onkol; 1970; 16(7):17-20. PubMed ID: 5482837
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of mastisol (2-alpha-methylandrostan-17-beta-ol-3-one propionate) and testosterone propionate in the treatment of advanced and recurrent cancer of the breast.
    Amaaki T; Enomoto K; Shimada S; Nagai K; Minagawa N
    Nihon Geka Hokan; 1969 Jul; 38(4):652-7. PubMed ID: 5394603
    [No Abstract]   [Full Text] [Related]  

  • 3. [Excretion of hormones in patients with cancer of the breast after hormone loading with testosterone-propionate].
    Olinia AIa
    Klin Lech Zlokach Novoobraz; 1968; 11():79-92. PubMed ID: 5725417
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study of urinary 17-ketosteroid fractions in breast cancer--correlation with the effect of adrenalectomy in progressive breast cancer].
    Sakauchi N; Abe O; Kusama M; Takatani O; Kato N
    Saishin Igaku; 1968 Feb; 24(2):463-70. PubMed ID: 4239286
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study on the fractionation of urinary 17-ketosteroids in the field of urology. VI. Urinary 17-ks fractions after testosterone administration and long-term treatment of testosterone propionate in male hypogonadism].
    Sonoda T
    Nihon Hinyokika Gakkai Zasshi; 1967 Nov; 58(11):1134-45. PubMed ID: 5628203
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of 17-ketosteroid fractions in patients with uterine hemorrhage treated with testosterone and infecundine].
    Manuilova IA; Aronovich AS; Bass ZhZh
    Akush Ginekol (Mosk); 1969 Oct; 45(10):21-4. PubMed ID: 5381556
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the 17-Ketosteroid and testosterone determination in the urine of advanced gravidae].
    Seiler E; Schollberg K; Sengebusch WD
    Z Arztl Fortbild (Jena); 1969 Feb; 63(3):137-9. PubMed ID: 5785461
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic changes in breast carcinoma. I. Urinary excretions of ketosteroid and catecholamine.
    Maity CR; Burma DP
    Indian J Cancer; 1973 Sep; 10(3):351-5. PubMed ID: 4785883
    [No Abstract]   [Full Text] [Related]  

  • 9. [Concentration of 17-ketosteroids in the urine of breast cancer patients].
    Smiller RR
    Vopr Onkol; 1965; 11(10):39-43. PubMed ID: 5872967
    [No Abstract]   [Full Text] [Related]  

  • 10. [Low frequency vibration and testosterone levels in blood serum and excretion of 17-ketosteroid in urine in exposed workers].
    Wegiel A; Pigoń-Wegiel A; Dec M
    Med Pr; 1993; 44(6):569-72. PubMed ID: 8107572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Androgens in treatment of metastatic breast cancer].
    Horn Y; Horn H; Gordan GS
    Harefuah; 1972 Dec; 83(12):584-5. PubMed ID: 4659031
    [No Abstract]   [Full Text] [Related]  

  • 12. [Suitability of sex-chromatin determination for the hormonal treatment of breast cancer].
    Krejczy K
    Pol Przegl Chir; 1966 Jun; 38(6):548-54. PubMed ID: 5963367
    [No Abstract]   [Full Text] [Related]  

  • 13. [A study on androgen in urological fields. Study on urinary 17-ketosteroid fractions and testosterone radioactivity].
    Takata M
    Nihon Hinyokika Gakkai Zasshi; 1970 Feb; 61(2):135-51. PubMed ID: 5462391
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hormone treatment of breast cancer in the advanced phase].
    Demol R
    Brux Med; 1968 Oct; 48(10):665-9. PubMed ID: 5757971
    [No Abstract]   [Full Text] [Related]  

  • 15. Testosterone treatment and 17-ketosteroid excretion. V. Administration of testosterone per rectum.
    HAMBURGER C
    Acta Endocrinol (Copenh); 1958 Aug; 28(4):529-36. PubMed ID: 13570882
    [No Abstract]   [Full Text] [Related]  

  • 16. [Urinary excretion of neutral 17-ketosteroids, androsterone and etiocholanolone in healthy women and women with early and advanced breast cancer].
    Bacigalupo G; Lingk H
    Arch Geschwulstforsch; 1968; 32(1):95-107. PubMed ID: 5678251
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of the presence at determinable levels of free plasma 17-ketosteroids on the survival of breast cancer patients].
    Seeman A; Saracino R; Bourdin JS; Bénard H
    C R Acad Hebd Seances Acad Sci D; 1971 Jan; 272(1):167-9. PubMed ID: 4994964
    [No Abstract]   [Full Text] [Related]  

  • 18. [The hormone treatment of breast carcinomas, with reference to Bar cell nucleus body findings].
    Ehlers PN; Hochberg K; Nuri M
    Bull Soc Int Chir; 1966; 25(3):293-9. PubMed ID: 5917121
    [No Abstract]   [Full Text] [Related]  

  • 19. [Letter: Testosterone suppositories DAK].
    Hamburger C
    Ugeskr Laeger; 1974 Feb; 136(6):307-8. PubMed ID: 4820554
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of metastasizing breast cancer with anabolic steroids].
    Hortling H; Malmio K
    Nord Med; 1967 Mar; 77(9):275-9. PubMed ID: 6020758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.